[ad_1]
Swedish-British Astra Zeneca reports on a successful phase 3 study of its COVID-19 vaccine in the US.
No problems with side effects in the form of blood clots appear in the study.
The Covid-19 vaccine from Astra Zeneca and Oxford University shows 79% protection in a large study conducted in the US According to tests, the vaccine also shows 100% protection against a severe and critical course of illness and the need for hospital care, writes Astra Zeneca in a press release.
The so-called phase 3 study, which is completed like this, is the last stop before applying for a permit from the US Drug Administration FDA.
The report comes after the European Medicines Agency EMA and the World Health Organization (WHO) determined that the benefits of the vaccine outweigh the risk of side effects in the form of blood clots, which are investigated after several deaths. reported among people who took the vaccine. in Sweden, Norway and Denmark.
According to Astra Zeneca, an independent committee has specially studied the presence of blood clots in the US tests, including the presence of the unusual form of cerebrovascular disease, which can cause blood clots in the brain, which has been reported. in the EU.
The committee has not found an increased risk of blood clots among the 21,583 participants who received the vaccine in the now-completed study in the U.S. And, according to Astra Zeneca, there is no case in the study of the most unusual form of blood clots in the brain. .
Joakim Goksör / TT
This is how SLA works with journalism: the information that is published must be truthful and relevant. We strive to get first-hand sources and be where it happens. Credibility and fairness are core values for our news journalism.
[ad_2]
